Healthcare Industry News:  Penumbra Inc. 

Devices Interventional Product Launch

 News Release - February 4, 2013

Penumbra Inc. Launches 5MAX DDC(TM) and 4MAX DDC(TM) Distal Delivery Catheters

Penumbra Inc. launches new DDC family to aid in the delivery of a broad array of neurovascular therapies at the 3rd SNIS International Endovascular Stroke Conference and Joint Cerebrovascular Section Annual Meeting

HONOLULU--(Healthcare Sales & Marketing Network)--The Penumbra 5MAX DDC and 4MAX DDC distal delivery catheters are new devices designed to simplify delivery of a wide variety of endovascular therapies to the brain. The DDC family delivers exceptional distal delivery capability via a novel advanced polymer and nitinol coil reinforcement design at the distal tip to enable easy tracking through tortuous vessels. All DDC catheters have large tapered lumens, which are compatible with most microcatheter-delivered neuro endovascular therapies today. The DDC exclusive tapered lumen design enables higher contrast flow and better visualization while maintaining the flexibility to help physicians deliver therapies more efficiently.

“The support provided by the 4MAX DDC helped stabilize the tip of my coil delivery catheter enabling significantly more control over coil loops as I delivered and positioned them in a very challenging aneurysm.” said John M. Whapham, MD, MS, FSNIS, Medical Director of Stroke and Endovascular Neurosurgery at Mercy St. Vincent’s Medical Center in Toledo, Ohio who performed one of the first DDC cases in the United States. “The new 4MAX DDC design tracked significantly more smoothly than currently available intermediate catheters and thus may help reduce vessel trauma. Further, it provides the first practical delivery technology which combines guide catheter-like support proximally, with microcatheter-like properties as it is navigated more distally.”

Dr. Whapham continued, “The DDC family will be my go-to catheter for a wide variety of patients and therapies due to the ability to bring a stable catheter construct to even the most distal anatomy.”

Penumbra is launching this new technology at the 3rd SNIS InternationalEndovascular Stroke Conference (IESC)and Joint Cerebrovascular Section Annual Meeting taking place this week in Honolulu, Hawaii. This meeting brings together leading neuro-specialists from around the world and is jointly sponsored by the Society of Neurointerventonal Surgeons and the Joint Cerebrovascular Section of AANS and CNS.

ABOUT Penumbra, Inc.

Penumbra, Inc. is an independent medical device company committed to delivering clinically beneficial products that help patients suffering from stroke and other vascular diseases. Penumbra’s global headquarters is located in Alameda, California with sales operations in North and South America, Europe, Australia and Asia.

ABOUT The Distal Delivery Catheter Family

The Penumbra DDC family can be used to deliver a broad array of neuro-endovascular therapies with its unique combination of exceptional trackability and large, tapered lumens for optimal visualization. The DDC family is available in a wide variety of length and diameter combinations to accommodate many therapy delivery configurations.

Source: Penumbra Inc.

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.